Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression
Status:
Completed
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
We are trying to understand what causes bipolar disorder and how medications treat bipolar
depression. Particularly, we are looking at the importance of inflammation in the process. If
you participate, you will have two different brain scans (MRI and PET scan). You will also
have an experimental treatment for your depression named N-acetyl cysteine (NAC). The study
is funded by the Columbia University Irving Institute to improve the treatment of bipolar
disorder. Please contact us if you are interested in participating. Up to $600 in
compensation if you are eligible and choose to participate. Up to 6 months of treatment for
depression at no cost to you.